MeSH tree: C04.557.470.670.380.590
Low-grade brain tumors known as IDH-mutant gliomas CNS WHO grade 2 are life-threatening in spite of their slow growth. Neurosurgeons across the globe are faced with the question as to striking the correct balance between ...
Jan 19, 2026
0
20
A new research paper titled "BCAS1 defines a heterogeneous cell population in diffuse gliomas" has been published in Oncotarget.
Jan 31, 2024
0
20
Diffuse gliomas, which account for the majority of malignant brain tumors in adults, comprise astrocytoma, oligodendroglioma, and glioblastoma. Current diagnosis of glioma types requires combining both histological features ...
Nov 24, 2023
0
37
A research team from the Suzhou Institute of Biomedical Engineering and Technology (SIBET) of the Chinese Academy of Sciences, in collaboration with researchers from the Xiangya Hospital of Central South University, has proposed ...
May 23, 2023
0
47
A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations on the use of radiation therapy to treat patients with isocitrate dehydrogenase (IDH)-mutant grade 2 and grade 3 diffuse ...
Aug 31, 2022
0
80
